1-2 of 2
Ross Andrew Soo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

Open Access
Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia, Jianying Zhou, Dong-Wan Kim, Ross Andrew Soo, Ying Cheng, Shun Lu, Sang Won Shin, James Chih-Hsin Yang, Yiping Zhang, Jun Zhao, Karin Berghoff, Rolf Bruns, Andreas Johne, Yi-Long Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (10): 1879–1886.
https://doi.org/10.1158/1078-0432.CCR-22-3318
Published: 15 May 2023
View articletitled, Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis
Open the PDF for Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis in another window
Includes: Supplementary data
Journal Articles

Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma

Available to Purchase
Wan Qin Chong, Chwee Ming Lim, Arvind Kumar Sinha, Chee Seng Tan, Gloria Hui Jia Chan, Yiqing Huang, Nesaretnam Barr Kumarakulasinghe, Raghav Sundar, Anand D. Jeyasekharan, Woei Shyang Loh, Joshua K. Tay, Kritika Yadav, Lingzhi Wang, Andrea L. Wong, Li Ren Kong, Ross Andrew Soo, Jieying Amelia Lau, Yu Yang Soon, Robby Miguel Goh, Francis Cho Hao Ho, Siew Meng Chong, Soo Chin Lee, Kwok Seng Loh, Bee Choo Tai, Yaw Chyn Lim, Boon Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5320–5328.
https://doi.org/10.1158/1078-0432.CCR-20-1727
Published: 15 October 2020
View articletitled, Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
Open the PDF for Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma in another window
Includes: Supplementary data